Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their
growth. This phase II trial is studying how well lapatinib works in treating brain metastases
in patients with stage IV breast cancer and brain metastases.